GLP-1s can help with the weight and metabolic challenges, but they work best when combined with lifestyle strategies that address the unique needs of your changing body
doi: 10.1186/s12974-022-02398-x, 40 GaoM.YiJ.ZhuJ.MinikesA
Key Takeaways (Summary): The Proposal: The FDA is moving to remove three major GLP-1 drugs from the 503B bulks list, which would prevent outsourcing facilities from compounding them using bulk substances
It may even double the death rate for some cancer patients
What is not proven: Human RCTs have not established that raised blood GSH levels from oral supplementation produce clinically meaningful outcomes in healthy adults including permanent skin lightening, reliable liver protection, or cognitive enhancement
Although technically challenging, this should be further investigated, especially in light of the neuroimaging findings in ME/CFS, described in the following paragraphs